|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
1 Department of Human Anatomy and Histology, University of Bari, Italy
2 M.I.A. Dibit-hsr et University of Milano Bicocca-Monza, Milan, Italy
3 Department of Internal Medicine, University of Bari, Italy
4 Department of Cell Biology and The Scripps Research Institute, La Jolla,
USA
* Author for correspondence (e-mail: faccio{at}pathology.wustl.edu )
Accepted 19 April 2002
Integrins are membrane receptors that mediate interactions between cells
and the extracellular matrix. We recently showed that the osteoclast integrin
vß3 exists in two different conformations,
so-called `basal' and `activated', with each exhibiting a distinct function.
In this study we demonstrate that, in non-resorbing osteoclasts, the
`activated' form of
vß3 accumulates in the
motile areas of the plasma membrane. During bone resorption this conformation
is prevalent in the ruffled membrane, whereas the `basal' form of
vß3 is also present in the sealing zone.
Moreover, hepatocyte growth factor (HGF) and macrophage colony stimulating
factor (M-CSF), two molecules involved in osteoclastogenesis and osteoclast
survival, modulate
vß3 conformation in
vitro. Preincubation with HGF or M-CSF induces a shift of conformation of
vß3 in primary human osteoclasts (OCs) and
in the osteoclast-like cell line (GCT 23). Activated integrin promotes
osteoclast migration to the
vß3 ligand
osteopontin and enhances bone resorption. Thus, HGF and M-CSF modulate the
vß3 conformational states required for
osteoclast polarization and resorption. The capacity of growth factors to
alter the affinity of
vß3 toward its ligands
offers a potential explanation for the diverse responses of osteoclasts to the
same ligand.
Key words: Osteoclasts, Alpha v beta 3, Integrin, HGF, M-CSF
This article has been cited by other articles:
![]() |
G. N. M. Hajj, M. H. Lopes, A. F. Mercadante, S. S. Veiga, R. B. da Silveira, T. G. Santos, K. C. B. Ribeiro, M. A. Juliano, S. G. Jacchieri, S. M. Zanata, et al. Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins J. Cell Sci., June 1, 2007; 120(11): 1915 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Saltel, O. Destaing, F. Bard, D. Eichert, and P. Jurdic Apatite-mediated Actin Dynamics in Resorbing Osteoclasts Mol. Biol. Cell, December 1, 2004; 15(12): 5231 - 5241. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Calle, G. E. Jones, C. Jagger, K. Fuller, M. P. Blundell, J. Chow, T. Chambers, and A. J. Thrasher WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption Blood, May 1, 2004; 103(9): 3552 - 3561. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rolli, E. Fransvea, J. Pilch, A. Saven, and B. Felding-Habermann Activated integrin {alpha}v{beta}3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells PNAS, August 5, 2003; 100(16): 9482 - 9487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Faccio, D. V. Novack, A. Zallone, F. P. Ross, and S. L. Teitelbaum Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by {beta}3 integrin J. Cell Biol., August 4, 2003; 162(3): 499 - 509. [Abstract] [Full Text] [PDF] |
||||